Intracranial Atherosclerosis

Farhan Siddiq; Burhan Z. Chaudhry; Adnan I Qureshi

doi:10.1002/9781444308198.ch15

Intracranial Atherosclerosis

Farhan Siddiq
, Burhan Z. Chaudhry
, Adnan I Qureshi

Neurology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Original language	English (US)
Title of host publication	A Primer on Stroke Prevention Treatment
Subtitle of host publication	An Overview Based on AHA/ASA Guidelines
Publisher	Wiley-Blackwell
Pages	195-205
Number of pages	11
ISBN (Print)	9781405186513
DOIs	https://doi.org/10.1002/9781444308198.ch15
State	Published - Apr 8 2009

Bibliographical note

Funding Information:
AIQ has received funding from the National Institutes of Health (RO1-NS44976–01A2; drugs provided by ESP Parma), the American Heart Association Established Investigator Award (0840053N), the National Institutes of Health (U01-NS062091–01A2, drugs provided by Cornerstone Therapeutics), and the Minnesota Medical Foundation. LRC declares that he has no conflicts of interest.

Keywords

Anticoagulation - patients with atherosclerotic disease
Intracranial stenosis and atherosclerosis
Intravascular ultrasonography (IVUS)
Magnetic resonance angiography (MRA)
Primary angioplasty versus stent placement - intracranial stenosis

Publisher link

10.1002/9781444308198.ch15

Find It

Find It at U of M Libraries

Cite this

@inbook{5abcaa611bc747cca9445796704219cf,

title = "Intracranial Atherosclerosis",

keywords = "Anticoagulation - patients with atherosclerotic disease, Intracranial stenosis and atherosclerosis, Intravascular ultrasonography (IVUS), Magnetic resonance angiography (MRA), Primary angioplasty versus stent placement - intracranial stenosis",

author = "Farhan Siddiq and Chaudhry, \{Burhan Z.\} and Qureshi, \{Adnan I\}",

note = "Funding Information: AIQ has received funding from the National Institutes of Health (RO1-NS44976–01A2; drugs provided by ESP Parma), the American Heart Association Established Investigator Award (0840053N), the National Institutes of Health (U01-NS062091–01A2, drugs provided by Cornerstone Therapeutics), and the Minnesota Medical Foundation. LRC declares that he has no conflicts of interest.",

year = "2009",

month = apr,

day = "8",

doi = "10.1002/9781444308198.ch15",

language = "English (US)",

isbn = "9781405186513",

pages = "195--205",

booktitle = "A Primer on Stroke Prevention Treatment",

publisher = "Wiley-Blackwell",

}

TY - CHAP

T1 - Intracranial Atherosclerosis

AU - Siddiq, Farhan

AU - Chaudhry, Burhan Z.

AU - Qureshi, Adnan I

N1 - Funding Information: AIQ has received funding from the National Institutes of Health (RO1-NS44976–01A2; drugs provided by ESP Parma), the American Heart Association Established Investigator Award (0840053N), the National Institutes of Health (U01-NS062091–01A2, drugs provided by Cornerstone Therapeutics), and the Minnesota Medical Foundation. LRC declares that he has no conflicts of interest.

PY - 2009/4/8

Y1 - 2009/4/8

KW - Anticoagulation - patients with atherosclerotic disease

KW - Intracranial stenosis and atherosclerosis

KW - Intravascular ultrasonography (IVUS)

KW - Magnetic resonance angiography (MRA)

KW - Primary angioplasty versus stent placement - intracranial stenosis

UR - https://www.scopus.com/pages/publications/84889444417

UR - https://www.scopus.com/pages/publications/84889444417#tab=citedBy

U2 - 10.1002/9781444308198.ch15

DO - 10.1002/9781444308198.ch15

M3 - Chapter

AN - SCOPUS:84889444417

SN - 9781405186513

SP - 195

EP - 205

BT - A Primer on Stroke Prevention Treatment

PB - Wiley-Blackwell

ER -

Intracranial Atherosclerosis

Bibliographical note

Keywords

Publisher link

Find It

Other files and links

Cite this